Nobiastx
1 known investors
Nobias Therapeutics develops small-molecule drug candidates for genetically-defined rare diseases, primarily in pediatric populations. The company leverages genomic datasets and partnerships with pediatric academic medical centers across North America to accelerate drug discovery.
Biotech